MedPath

Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols

Phase 2
Conditions
Cholesterol; Metabolic Disorder
Metabolic Syndrome
Registration Number
NCT03584581
Lead Sponsor
Universidad Miguel Hernandez de Elche
Brief Summary

This study is designed to determine whether a standardized intervention in the health center and based on hygienic dietary measures and physical exercise, supplemented with a polyphenol extract in patients, achieves a greater benefit in the reduction of LDL cholesterol in dyslipidemias in the short term.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with dyslipidemia without the need for pharmacological treatment, but with annual follow-up of their dyslipidemia and with baseline LDL-cholesterol values.
  • Patients to whom the annual analysis will be carried out for control of the lipid profile and who agree to postpone it during the month of the health education study.
  • Patients who undergo hygienic-dietetic intervention and exercise.
  • Patients willing to ingest the nutritional supplement of polyphenols that will be supplied to them.
  • Signed the informed consent.
Exclusion Criteria
  • <18 years old.
  • High cardiovascular risk.
  • With pharmacological treatment.
  • With some previous chronic disease.
  • With some allergy to the compounds of the product and placebo according to the technical specifications.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cholesterols levels1 month

TC, HDL-C, LDL-C and TG.

Secondary Outcome Measures
NameTimeMethod
BMI (kg/m2)1 month

Weight and height will be combined to report BMI in kg/m\^2

Waist circumference (cm)1 month
Blood pressure1 month

SBP and DBP.

Trial Locations

Locations (1)

General University Hospital of Elda

🇪🇸

Elda, Alicante, Spain

General University Hospital of Elda
🇪🇸Elda, Alicante, Spain
Vicente F Gil-Guillén, MD, PhD
Sub Investigator
Ernesto Cortés-Castell, PhD
Principal Investigator
Antonio Palazón-Bru, PhD
Sub Investigator
María M Rizo-Baeza, PhD
Sub Investigator
Luís Torró-Montell, MPharm
Sub Investigator
Enrique Hermida-Campa, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.